PBYI - Puma Biotechnology Q3 2020 Earnings Preview
Puma Biotechnology (NASDAQ:PBYI) is scheduled to announce Q3 earnings results on Thursday, November 5th, after market close.The consensus EPS Estimate is -$0.14 (-16.7% Y/Y) and the consensus Revenue Estimate is $52.97M (-6.1% Y/Y).Over the last 2 years, PBYI has beaten EPS estimates 100% of the time and has beaten revenue estimates 88% of the time.Over the last 3 months, EPS estimates have seen 0 upward revisions and 2 downward. Revenue estimates have seen 0 upward revisions and 8 downward.
For further details see:
Puma Biotechnology Q3 2020 Earnings Preview